Evidence exists that the risk for a wide range of chronic diseases increases with age. For many of these diseases effective pharmacological interventions are lacking. Hence, any intervention that can slow aging can also reduce the potential of contracting such illnesses. Although several compounds are currently under investigation for their life span extending effects, the complexity of the aging phenotype makes this search difficult. In this project we combine two emerging strategies for drug discovery, namely in silico pharmacology and the use of invertebrate whole-animal models.
Aim 1 will provide a collection of candidate compounds by performing a large-scale bioinformatics screen of over 1,300 pharmacological agents. To do this we will utilize a novel gene list comparison algorithm we have developed to identify significant associations between expression changes induced by drug treatment and expression changes observed in interventions that extend healthspan.
Aim 2 will test the effect of drugs identified in Aim 1 in Drosophila melanogaster. Flies will be fed each compound over the course of their adult life, and their life span as well as their response to stressors will be monitored and compared to that of flies on control food. The proposed work will develop an important new bioinformatics strategy to screen for longevity drugs and has the potential to identify several novel compounds that extend life span.
Aim 3 will utilize the same data collected in Aim 1 but will use a complementary approach in which shared regulatory elements will be identified in the promoters of the genes in the common signatures between drugs and healthspan interventions.

Public Health Relevance

Because aging is the leading risk factor for many chronic illnesses, interventions that can slow aging have the potential to significantly reduce the impact of such diseases and extend healthspan in humans. The comprehensive research design of this proposal has the potential to identify novel pharmacological compounds that can slow aging in model organisms, and ultimately lead to the development of drugs to ameliorate some of the deleterious consequences of aging and age-related disorders in humans.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brown University
United States
Zip Code
Bryner, Darshan; Criscione, Stephen; Leith, Andrew et al. (2017) GINOM: A statistical framework for assessing interval overlap of multiple genomic features. PLoS Comput Biol 13:e1005586
Cabral, Damien J; Wurster, Jenna I; Flokas, Myrto E et al. (2017) The salivary microbiome is consistent between subjects and resistant to impacts of short-term hospitalization. Sci Rep 7:11040
Nakka, Priyanka; Archer, Natalie P; Xu, Heng et al. (2017) Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case-Control and Family-Based Studies in Multiethnic Populations. Cancer Epidemiol Biomarkers Prev 26:1531-1539
Gamradt, Pia; Xu, Yun; Gratz, Nina et al. (2016) The Influence of Programmed Cell Death in Myeloid Cells on Host Resilience to Infection with Legionella pneumophila or Streptococcus pyogenes. PLoS Pathog 12:e1006032
Criscione, Steven W; Teo, Yee Voan; Neretti, Nicola (2016) The Chromatin Landscape of Cellular Senescence. Trends Genet 32:751-761
Sugden, Lauren Alpert; Ramachandran, Sohini (2016) Integrating the signatures of demic expansion and archaic introgression in studies of human population genomics. Curr Opin Genet Dev 41:140-149